Fielder Capital Group LLC bought a new stake in Centene Corporation (NYSE:CNC – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 7,648 shares of the company’s stock, valued at approximately $491,000.
A number of other institutional investors and hedge funds have also modified their holdings of CNC. DV Equities LLC acquired a new stake in Centene during the 4th quarter worth $26,000. Elevation Wealth Partners LLC lifted its stake in shares of Centene by 564.6% in the 2nd quarter. Elevation Wealth Partners LLC now owns 658 shares of the company’s stock valued at $42,000 after purchasing an additional 559 shares during the period. IFC & Insurance Marketing Inc. bought a new position in shares of Centene in the 4th quarter worth $28,000. SBI Securities Co. Ltd. increased its holdings in Centene by 118.4% in the fourth quarter. SBI Securities Co. Ltd. now owns 749 shares of the company’s stock valued at $31,000 after purchasing an additional 406 shares during the last quarter. Finally, Bayban bought a new stake in Centene in the fourth quarter valued at about $33,000. 93.63% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
Several research firms have recently issued reports on CNC. TD Cowen restated a “hold” rating and set a $65.00 target price (up from $47.00) on shares of Centene in a research report on Tuesday, July 14th. Zacks Research raised shares of Centene from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, July 29th. Oppenheimer upped their target price on shares of Centene from $58.00 to $67.00 and gave the company an “outperform” rating in a research note on Wednesday, May 27th. Royal Bank Of Canada increased their target price on shares of Centene from $70.00 to $71.00 and gave the stock a “sector perform” rating in a report on Thursday, July 9th. Finally, Bank of America upped their price objective on shares of Centene from $72.00 to $74.00 and gave the company a “buy” rating in a research report on Thursday, June 4th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, nine have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $69.15.
Centene Stock Performance
Shares of NYSE CNC opened at $67.53 on Monday. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.15 and a current ratio of 1.15. The stock has a 50 day moving average price of $65.00 and a 200 day moving average price of $51.69. The stock has a market capitalization of $33.36 billion, a PE ratio of -6.47, a price-to-earnings-growth ratio of 0.36 and a beta of 1.08. Centene Corporation has a 52 week low of $27.76 and a 52 week high of $69.36.
Centene (NYSE:CNC – Get Free Report) last posted its quarterly earnings results on Tuesday, July 28th. The company reported $2.51 earnings per share for the quarter, topping the consensus estimate of $1.09 by $1.42. The firm had revenue of $53.58 billion for the quarter, compared to analyst estimates of $47.64 billion. Centene had a positive return on equity of 12.12% and a negative net margin of 2.51%.The business’s quarterly revenue was up 9.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.16) EPS. Centene has set its FY 2026 guidance at 4.800- EPS. Analysts predict that Centene Corporation will post 4.89 earnings per share for the current fiscal year.
Centene Profile
Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.
Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.
Featured Stories
- Five stocks we like better than Centene
- The Metals Company’s Big Bet Now Comes Down to a License
- OneSpaWorld Keeps Turning Cruise Demand Into Record Earnings
- Meta and Tesla Are Rebounding From Oversold Levels—Now What?
- AMG’s Alternatives Boom Powers Record Growth
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
